Healthcare Of Ontario Pension Plan Trust Fund Exelixis, Inc. Transaction History

Healthcare Of Ontario Pension Plan Trust Fund

$40.7 Billion
Q3 2024

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$20.17 - $23.93 $198,412 - $235,399	9,837 New	9,837 $233,000
Q2 2023 Aug 11, 2023	BUY	$18.17 - $20.48 $1.75 Million - $1.97 Million	96,416 Added 1288.3%	103,900 $1.99 Million
Q1 2023 May 12, 2023	SELL	$16.3 - $19.41 $5,770 - $6,871	-354 Reduced 4.52%	7,484 $145,000
Q4 2022 Feb 13, 2023	SELL	$14.96 - $17.39 $81,008 - $94,166	-5,415 Reduced 40.86%	7,838 $125,000
Q3 2022 Nov 14, 2022	BUY	$15.68 - $22.27 $11,023 - $15,655	703 Added 5.6%	13,253 $208,000
Q2 2022 Aug 11, 2022	BUY	$17.44 - $23.16 $218,872 - $290,658	12,550 New	12,550 $261,000
Q3 2021 Nov 10, 2021	SELL	$16.3 - $21.14 $18,402 - $23,867	-1,129 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$17.95 - $25.56 $21,324 - $30,365	-1,188 Reduced 51.27%	1,129 $21,000
Q1 2021 May 13, 2021	BUY	$20.53 - $25.22 $47,568 - $58,434	2,317 New	2,317 $52,000
Q1 2020 May 13, 2020	SELL	$14.46 - $21.8 $7.42 Million - $11.2 Million	-513,000 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$15.15 - $18.89 $7.77 Million - $9.69 Million	513,000 New	513,000 $9.04 Million

Others Institutions Holding EXEL

# of Institutions

501

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

Black Rock Inc. New York, NY

33.5M
Shares

$1.19 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

29.3M
Shares

$1.04 Billion
0.01% of portfolio
Farallon Capital Management LLC San Francisco, CA

25.4M
Shares

$905 Million
3.31% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

15.4M
Shares

$547 Million
0.63% of portfolio
State Street Corp Boston, MA

11.4M
Shares

$408 Million
0.01% of portfolio

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.5B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Healthcare Of Ontario Pension Plan Trust Fund, based on Form 13F filings with the SEC.

News

Stay updated on Healthcare Of Ontario Pension Plan Trust Fund with notifications on news.

Account